CDK6 (DCS83) Mouse mAb产品图

CDK6 (DCS83) Mouse mAb

收藏
  • 询价
  • Cell Signaling Technology已认证
  • USA
  • 2026年05月28日
  • W
  • H,M,R
avatar
品牌商
13钻石会员
  • 企业认证

    • 详细信息
    • 文献和实验
    • 技术资料
    • 抗体英文名

      CDK6 (DCS83) Mouse mAb

    • 抗原

      recombinant human CDK6 corresponding to amino acids 30-65

    • 应用范围

      W

    • 级别

      详见MSDS文件

    • 适应物种

      H,M,R

    • 供应商

      CST

    • 保质期

      详见说明书

    • 库存

      大量

    • 是否单克隆

      1

    • 保存条件

      -20°c

    • 规格

      40 ul (8 western blots)/100 ul (20 western blots)/carrier free & custom formulation / quantity

    规格:产品价格:¥请询价
    规格:40 ul (8 western blots)产品价格:¥请询价
    规格:100 ul (20 western blots)产品价格:¥请询价
    规格:carrier free & custom formulation / quantity产品价格:¥请询价

    pathway more info application references datasheet PDF MSDS PDF protocols

    Applications Key:  W=Western Blotting
    Reactivity Key:  H=Human  M=Mouse  R=Rat
    Species cross-reactivity is determined by western blot. Species enclosed in parentheses are predicted to react based on 100% sequence homology.

    Applications Reactivity Sensitivity MW (kDa) Isotype
    W H M R Endogenous 36 Mouse IgG1
    Protocols
    Specificity / Sensitivity

    CDK6 (DCS83) Mouse mAb detects endogenous levels of total CDK6 protein.

    Source / Purification

    Monoclonal antibody is produced by immunizing animals with recombinant human CDK6 corresponding to amino acids 30-65.

    Western Blotting

    Western Blotting

    Western blot analysis of extracts from HeLa, IM-CD-3 and C6 cells, using CDK6 (DCS83) Mouse mAb.

    Background

    The cyclin-dependent kinases form complexes with their cyclin partners and with CDK inhibitors. CDK6 and CDK4 associate with the D-type cyclins and target the retinoblastoma protein, allowing passage through the G1/S phase restriction point (1). CDK6/cyclin D complexes are sequestered in their inactive form through binding to one of the INK4 CDK inhibitor family members (2,3). Unlike the INK4 family of cdk inhibitors, the CDK inhibitor p21 Waf1/Cip1 may enhance the association of CDK4 and CDK6 with their cyclin D partners (4).

    1. Lukas, J. et al. (1996) Mol. Cell. Biol. 16, 6917-1625.
    2. Hirai, H. et al. (1995) Mol. Cell. Biol. 15, 2672-2681.
    3. Pestell, R.G. et al. (1999) Endocr. Rev. 20, 501-534.
    4. Flores-Rozas, H. et al. (1994) Proc. Natl. Acad. Sci. USA 91, 8655-8659.
    Application References

    Have you published research involving the use of our products? If so we'd love to hear about it. Please let us know !

    Companion Products

    For Research Use Only. Not For Use In Diagnostic Procedures.

    风险提示:丁香通仅作为第三方平台,为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全,合理判断,谨慎选购商品,商家和用户对交易行为负责。对于医疗器械类产品,请先查证核实企业经营资质和医疗器械产品注册证情况。

    图标文献和实验
    该产品被引用文献
    [1]FTO-mediated m6A modification of protein disulfide-isomerase activates VEGFA-VEGFR2 to suppress programmed cell death in osteosarcoma
    PMID:42246398J Pathol2026-06-05
    [2]Influence of stage-specific and location-related intratumoral microbiota on prognosis and metabolic reprogramming in non-small cell lung cancer.
    PMID:41562055Front Immunol2026-01-05
    [3]Mechanisms of Zanthoxyli Pericarpium-Zingiberis Rhizoma in the Treatment of Gastric Cancer Based on Network Pharmacology and Experimental Validation.
    PMID:40464032Drug Des Devel Ther2025-05-30
    [4]Integrative Pan-Cancer Analysis Reveals the Oncogenic Role of MND1 and Validation of MND1's Role in Breast Cancer.
    PMID:39051055J Inflamm Res2024-07-17
    [5]Targeting dual-specificity tyrosine phosphorylation-regulated kinase 2 with a highly selective inhibitor for the treatment of prostate cancer.
    PMID:35614066Nat Commun2022-05-25
    [6]CDK6 increases glycolysis and suppresses autophagy by mTORC1-HK2 pathway activation in cervical cancer cells.
    PMID:35167417Cell Cycle2022-05
    [7]INK4 Tumor Suppressor Proteins Mediate Resistance to CDK4/6 Kinase Inhibitors
    PMID:34544752Cancer Discov2022-02
    [8]Deubiquitinase USP5 promotes non-small cell lung cancer cell proliferation by stabilizing cyclin D1.
    PMID:34858787Transl Lung Cancer Res2021-10
    [9]miR‑449a‑5p suppresses CDK6 expression to inhibit cardiomyocyte proliferation.
    PMID:33179102Mol Med Rep2021-01
    [10]Amphiphilic nanocarrier-induced modulation of PLK1 and miR-34a leads to improved therapeutic response in pancreatic cancer.
    PMID:29295989Nat Commun2018-01
    相关实验
    • DCs in Mouse Models of Intracellular Bacterial Infection

      Direct infection of antigen-presenting cells (APCs) with living intracellular bacteria may influence the early innate immune response as well as the following T-cell response. Revealing the identity of primarily targeted cells

    • Generation of Large Numbers of Pro-DCs and Pre-DCs In Vitro

      . In this chapter, we describe the very simple method of generating large numbers of in vitro-derived pro-DCs and pre-DCs. As these precursors are largely DC-restricted, they can be used to either reconstitute a mouse with DCs of desired background, to study

    • Purification of mAb (IgG)

      (adjust pH to 7.8 with Binding buffer; red color) to the Protein A column.Mouse antibodies of the IgG1 subclass do not have a high affinity for protein A. Purification on protein A beads using standard conditions will yield approximately 1/10

    图标技术资料

    暂无技术资料 索取技术资料

    同类产品报价

    产品名称
    产品价格
    公司名称
    报价日期
    询价
    美国CST中国公司(丁香通商铺)
    2023年10月16日询价
    ¥1632
    北京智杰方远科技有限公司
    2025年07月08日询价
    询价
    上海谷研实业有限公司
    2026年01月25日询价
    ¥5050
    上海瑶韵生物科技有限公司
    2025年03月17日询价
    询价
    赛默飞世尔科技
    2025年07月12日询价
    CDK6 (DCS83) Mouse mAb
    询价